FDA Hearing Focuses on Drug Promotions Online

Drug makers, Internet companies and nonprofits called for clarity on what is a gray area for U.S. health regulators: how drug promotion on Twitter, Wikipedia, blogs and other social media can be regulated. The two-day Food and Drug Administration hearing aims to find out if the agency needs to specifically regulate how drugs and medical devices it oversees are promoted on the Internet.

  • Read the article: Reuters

    • The GigaLaw Firm helps companies of all sizes protect their brands online, using domain name dispute policies – such as the Uniform Domain Name Dispute Resolution Policy (UDRP) – and other legal tools available to copyright and trademark owners on the Internet.